Results 141 to 150 of about 103,759 (240)

A Systematic Review and Meta‐Analysis on Campylobacter Species Prevalence in Chicken in Italy

Veterinary Medicine and Science, Volume 12, Issue 3, May 2026.
• This systematic review summarizes the prevalence of Campylobacter spp. in different chicken matrices in Italy over the last 20 years, which may be useful for conducting quantitative microbial risk assessment in the future. • Higher Campylobacter spp.
Aya Attia Koraney Zarea, Maria Francesca Iulietto, Tiina Mandel, Paola Scaramozzino, Roberto Condoleo   +4 more
wiley   +1 more source

What are the barriers and facilitators to advance care planning with older people in long‐term care facilities? A qualitative study

Journal of Clinical Nursing, Volume 35, Issue 5, Page 2356-2370, May 2026.
Abstract Aim To explore the views and preferences for advance care planning from the perspectives of residents, family members and healthcare professionals in long‐term care facilities. Design A qualitative descriptive design. Methods We conducted semi‐structured interviews with 12 residents of long‐term care facilities, 10 family members and 14 ...
Yuxin Zhou, Ariel Wang, Debbie Braybrook, Clare Ellis‐Smith, Haixia Feng, Ni Gong, Zhi Zhou, Richard Harding   +7 more
wiley   +1 more source

Case report: Guillain-Barre syndrome with pneumococcus – A new association in pediatrics

IDCases, 2018
Guillain-Barre Syndrome, an acute flaccid paralysis known to be caused by recent Gastro-intestinal infections mainly campylobacter, and Respiratory infections mainly mycoplasma pneumoniae and influenza.
Hassan El Khatib, Amal Naous, Soha Ghanem, Ghassan Dbaibo, Mariam Rajab   +4 more
doaj   +1 more source

Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?

Lancet Neurology, 2020
Huang-ning Zhao, Dingding Shen, Haiyan Zhou, Jun Liu, Sheng Chen   +4 more
semanticscholar   +1 more source

Presentación atípica del Síndrome de Guillain-Barré

Medicina Clínica y Social, 2019
El síndrome de Guillain-Barré (GBS) consiste en un grupo de afecciones neuropáticas caracterizadas por debilidad progresiva y reflejos disminuidos o ausentes.
Carol Maggi, Olivia Vian
doaj  

Fatal recurrent Guillain–Barré syndrome (GBS) in an Ethiopian male: a case report

Journal of Medical Case Reports
Introduction Guillain–Barré syndrome (GBS) is a disease affecting the peripheral nerves, leading to a constellation of motor, sensory, and autonomic symptoms.
Eden Tesfaye Beyene, Yonas Berhane Tesfay, Yared Getachew Tadesse, Estifanos Bekele Fole   +3 more
doaj   +1 more source

Impact of guillain barre syndrome on psychosocial functionings of patients in islamabad [PDF]

, 2014
GuillainBarre Syndrome (GBS) is a rare autoimmune disease of unknown causes that affects peripheral nervous system. Objectives: To review the impacts of the GuillainBarre Syndrome on the psychosocial functioning of the patients and to assess the ...
Ahmed Awan, Waqar, Naveed Babur, Muhammad, Shahzad, Farrukh   +2 more
core   +1 more source

Coexistence of familial mediterranean fever and guillain barre syndrome

Van Tıp Dergisi
Familial Mediterranean Fever (FMF) is the most common autoinflammatory disease characterized by recurrent episodes of abdominal pain, fever and serositis. It is more common in countries around the Mediterranean. Guillain Barre Syndrome (GBS) is an acute,
İsmail Tunçekin, Murat Toprak
doaj   +1 more source

Estimating the Costs and the Disease Burden Associated With Campylobacter Infections and Sequelae in the Netherlands [PDF]

Campylobacter infections pose an important public health problem in the Netherlands. Approximately 79,000 persons per year are estimated to experience symptoms of acute gastroenteritis.
Bernsen, Rob A.J.A.M., de Wit, G. Ardine, Havelaar, Arie H., Mangen, Marie-Josee J., van Koningsveld, Rinske   +4 more
core   +1 more source

Neurological complications of immune checkpoint inhibitors: what happens when you \u27take the brakes off\u27 the immune system. [PDF]

, 2018
Patients with advanced malignancies treated with immune checkpoint inhibitors are at increased risk for developing immune-related neurological complications.
Dalakas, Marinos
core   +1 more source